- Home
- MKDW vs OKUR Comparison
MKDW vs OKUR Comparison
Compare MKDW & OKUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKDW
- OKUR
- Stock Information
- Founded
- MKDW 2006
- OKUR 2011
- Country
- MKDW Taiwan
- OKUR United States
- Employees
- MKDW N/A
- OKUR N/A
- Industry
- MKDW
- OKUR
- Sector
- MKDW
- OKUR
- Exchange
- MKDW NYSE
- OKUR NYSE
- Market Cap
- MKDW 34.3M
- OKUR 34.9M
- IPO Year
- MKDW N/A
- OKUR N/A
- Fundamental
- Price
- MKDW $0.23
- OKUR $2.36
- Analyst Decision
- MKDW
- OKUR Strong Buy
- Analyst Count
- MKDW 0
- OKUR 4
- Target Price
- MKDW N/A
- OKUR $32.25
- AVG Volume (30 Days)
- MKDW 3.2M
- OKUR 71.0K
- Earning Date
- MKDW 07-29-2025
- OKUR 08-14-2025
- Dividend Yield
- MKDW N/A
- OKUR N/A
- EPS Growth
- MKDW N/A
- OKUR N/A
- EPS
- MKDW N/A
- OKUR N/A
- Revenue
- MKDW $3,670,722.00
- OKUR N/A
- Revenue This Year
- MKDW N/A
- OKUR N/A
- Revenue Next Year
- MKDW N/A
- OKUR N/A
- P/E Ratio
- MKDW N/A
- OKUR N/A
- Revenue Growth
- MKDW 16.40
- OKUR N/A
- 52 Week Low
- MKDW $0.17
- OKUR $1.70
- 52 Week High
- MKDW $5.52
- OKUR $20.00
- Technical
- Relative Strength Index (RSI)
- MKDW N/A
- OKUR N/A
- Support Level
- MKDW N/A
- OKUR N/A
- Resistance Level
- MKDW N/A
- OKUR N/A
- Average True Range (ATR)
- MKDW 0.00
- OKUR 0.00
- MACD
- MKDW 0.00
- OKUR 0.00
- Stochastic Oscillator
- MKDW 0.00
- OKUR 0.00
About MKDW MKDWELL TECH INC
MKDWell Tech Inc is a company engaged in supplying automotive electronics for passenger cars, modified commercial vehicles, camper vans and logistics vehicles. Its business coverage extends across the spectrum of research and development, design, production and sales of automotive electronic products. The main products are intelligent camper vans control systems, LiDAR sensors, intelligent container control systems for logistics vehicles, vehicle seat control system, and it provide customers with ODM and OEM customized services.
About OKUR ONKURE THERAPEUTICS INC
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company operates in one operating segment which is clinical research. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.